A wide spectrum of practice in sedation for gastrointestinal endoscopy in adult patients is documented overseas, but a current profile of the practice of Australian anaesthetists is unavailable. We therefore surveyed 200 Fellows of the Australian and New Zealand College of Anaesthetists on the choice of drugs and monitoring, use of analgesic throat spray and prophylactic intravenous fluids and the depth of sedation for gastrointestinal endoscopy. Our response rate was 57% and endoscopy formed a significant part of most respondents' practices. Propofol was used for almost all procedures, in combination with midazolam alone (14%), fentanyl alone (6%), midazolam and fentanyl (61%), another drug (15%) or no adjuvant (4%). The majority of patients received prophylactic intravenous fluids for endoscopic retrograde cholangio-pancreatography (83%) and colonoscopy (64%), but not for gastroscopy (20%). All patients received supplemental oxygen and monitoring with pulse oximetry. However, over 20% of patients having gastroscopy or colonoscopy did not have non-invasive blood pressure monitoring. A maximum depth of sedation during which the patient was unresponsive to painful stimulation (commensurate with general anaesthesia) was targeted by 54% of respondents. Significant variations exist in the practice of sedation and monitoring for endoscopy in adult patients by anaesthetists in Australia.
Gastrointestinal endoscopy is one of the commonly performed medical procedures on adult patients in Australia and is usually performed following the administration of sedative and/or analgesic drugs. The targeted depth of 'sedation' varies widely from conscious sedation through to general anaesthesia. While the risk associated with sedation or general anaesthesia for endoscopy is extremely low 1 , serious morbidity and even death may result from aspiration 2 . The challenge therefore remains to provide sedation that is safe, that meets the needs of the patient and the endoscopist and that allows the patient to resume work and other daily activities as soon as possible. The need to provide optimal sedation will only increase with the advent of widespread bowel cancer screening programs.
No consensus has been reached about the optimal drug combination for endoscopy, with different 3, 4 . For instance, Van Natta et al 3 stated that "propofol in combination with fentanyl and/or midazolam can be titrated to… shorter recovery times than propofol alone", while in contrast, Bevan et al 4 and Seifert et al 5 concluded that post-sedation recovery times are prolonged by midazolam. Anaesthetists are thus as much guided by their own training and experience, as by the literature, as to the best drug combinations to administer.
Several large surveys of sedation for endoscopy have been conducted in Switzerland 1 , the United Kingdom 6,7 and the United States of America 8 , but these focussed predominantly on the sedation practices of gastroenterologists and non-specialist anaesthetists. Our survey focuses on specialist anaesthetist practice in Australia. Our goal was to investigate the choice of drugs and monitoring, use
METHODS
Following approval by the Human Research Ethics Committee at The Royal Melbourne Hospital, a cross-sectional survey of Australian specialist anaesthetists was conducted. With assistance from the Australian and New Zealand College of Anaesthetists (ANZCA), a computer-generated random selection of 200 ANZCA Fellows was obtained. A sample size of 200 was considered an adequate representation of the 3300 ANZCA Fellows currently practicing in Australia. Each participant was assigned a unique identifying code, in order to track non-responders, and was then sent a copy of the survey, along with an explanatory letter and a reply-paid, coded return envelope. Initial non-responders were sent a reminder letter and a second copy of the survey four weeks later.
The survey consisted of 15 questions about the drugs, methods of drug delivery and depth of sedation used for gastrointestinal endoscopy, including oesophagogastroduodenoscopy (gastroscopy), endoscopic retrograde cholangiopancreatography (ERCP) and colonoscopy. In addition, anaesthetists were questioned about their standard monitoring choices and use of throat spray answer in relation to their routine practice in adult American Society of Anesthesiologists' physical status 1 to 2 patients, presenting for elective outpatient procedures.
The coded reply envelopes allowed us to establish which surveys had been returned. Envelopes were of participants.
Survey data were entered into a database and frequency distributions were generated. Results are presented as median (range), number (%) or odds comparisons were made using -squared or Fisher's exact tests. We explored predictors of midazolam a maximum depth of sedation in which the patient was unresponsive to painful stimulation, using logistic regression. These predictors included gender, region of practice, years of post-Fellowship experience and number of cases per month. All analyses were performed using Stata 9.0 and a P value <0.05 was 
RESULTS
Of the 200 surveys distributed, 113 were returned (response rate=57%). One survey contained no usable data and three respondents were retired. A further seven respondents did not practice sedation for endoscopy, leaving 102 surveys to be included in The demographic characteristics of the respondents were similar to those of ANZCA Fellows overall. The majority of respondents were Fellowship.
The geographical location of respondents was: New South Wales/Australian Capital Territory=28%; Victoria/Tasmania=28%; Queensland=24%;
South Australia/Northern Territory=11% and Western Australia=9%. Gastrointestinal endoscopy in adult patients formed practices: gastroscopy=10 (one to 60) cases per month, ERCP=two (one to 12) cases per month and colonoscopy=10 (one to 240) cases per month.
Propofol was used routinely by all respondents for all procedures, with the exception of one respondent who used midazolam and fentanyl without propofol for gastroscopy, one who used respondents administered propofol alone for any procedure, with most combining propofol with midazolam alone (14%), fentanyl alone (6%), midazolam and fentanyl (61%) or another drug (15%). Patients were more likely to receive propofol/midazolam/fentanyl for ERCP (P=0.03) or colonoscopy (P=0.001) than for gastroscopy and more likely to receive propofol/midazolam for gastroscopy than for ERCP (P=0.001) or colonoscopy (P <0.0001).
midazolam usage was the number of years post-Fellowship. During gastroscopy, midazolam was administered by 76% of respondents <10 years P=0.001). This comparison was not statistically P=0.47) or colonoscopy P=0.21). There were no differences in midazolam use with respect to gender, region of practice or the number of cases per month (results not shown).
Bolus dosing was the preferred method of propofol delivery for the majority of respondents. However, propofol was administered by manuallycontrolled or target-controlled infusion rather and colonoscopy patients (20%) than gastroscopy patients (8%) (P <0.0001) ( Table 1) .
All respondents administered supplemental oxygen and monitored patients using pulse oximetry. Non-invasive blood pressure monitoring was less likely to be used in patients having gastroscopy (P <0.0001) or colonoscopy (P=0.002) than patients having ERCP. Electrocardiographic (ECG) monitoring was also less likely to be used in patients having gastroscopy (P <0.0001) or colonoscopy (P <0.0001) than patients having ERCP. There were no differences in the use of capnography between the three procedures (P=0.132).
Endotracheal intubation, while uncommon (2% of cases), was more likely to occur during ERCP than during gastroscopy or colonoscopy (P <0.0001).
The majority of respondents (52%) used more likely to receive prophylactic intravenous P <0.0001) or colonoscopy (P <0.0001) than during gastroscopy. The only post-Fellowship. During colonoscopy, prophylactic <10 years post-Fellowship and 54% of anaesthetists P=0.046). This comparison was not P=0.65) or ERCP P=0.40). There were no differences in prophylactic of practice or the number of cases per month (results not shown).
Anaesthetists targeted a maximum depth of sedation in which patients were unresponsive to painful stimulation in 54% of patients. This maximum depth of sedation was targeted more often during ERCP than during gastroscopy (P=0.004). There were no other inter-procedure differences in depth of sedation. No predictors of maximum depth of sedation in which the patient was unresponsive to painful stimulation were 
DISCUSSION
This survey highlights some interesting features of the current practice of sedation for endoscopy in adult patients by Australian anaesthetists. The for patients requiring same-day discharge 9 , it is interesting that most respondents still add a longer acting agent, with a slower onset of action. The potential advantages of midazolam are its potent amnesic properties and its propofol dose-sparing effect, which may reduce the incidence of sideeffects 10, 11 . However, while several studies have reported that midazolam pre-treatment is requirement 12-15 respect to cardiovascular stability or incidence of apnoea has been found 14, 15 . In addition, in day case anaesthesia, co-induction with midazolam has been shown to impair psychomotor recovery in the immediate postoperative phase and at discharge 12, 15 .
The second interesting feature is the use of prevention of hypotension or for avoidance of troublesome postoperative symptoms such as thirst or nausea and vomiting 16, 17 .
In accordance with ANZCA guidelines, all anaesthetists used pulse oximetry and administered oxygen to patients during endoscopy 18 . However, non-invasive blood pressure monitoring was not used by around 20% of respondents for gastroscopy or colonoscopy. This is of concern since a depth of sedation commensurate with general anaesthesia was targeted for 50% of colonoscopies by respondents to this survey and hypotension (albeit mild and transient) is common during colonoscopy 17 . As guidelines clearly state that blood pressure should be recorded regularly 17, 19 , there is room for improvement in this area. ANZCA guidelines leave the use of ECG monitoring to the discretion of the anaesthetist. ECG monitoring was used routinely by less than 50% of respondents for patients having gastroscopy or colonoscopy, but we did not seek information about how the decision to use ECG monitoring was made.
Finally, there was a lack of uniformity in depth of sedation provided for endoscopy. This may endoscopists, anaesthetists and patients in Australia. Light sedation is practised commonly around the world and allows for more patient cooperation and a quicker recovery 20 . However, many patients are unable to tolerate endoscopy without deeper sedation. Deeper levels of sedation may facilitate a quicker and more complete examination, but carry the same risks as general anaesthesia 18 and may delay the diagnosis of complications such as bowel perforation.
The real question is whether these differences in elective gastrointestinal endoscopy in adult patients is a generally well-tolerated procedure 20 . In our opinion, there are at least two important answers. First, patients are under considerable pressure to assume their normal work and home responsibilities as soon as possible, so there is an onus on to facilitate this process. Second, patients and their carers are increasingly concerned about early cognitive dysfunction after anaesthesia and its effects on safety. Deep sedation and the use of midazolam (whose potential accumulation can result in prolonged sedation and a hangover effect 22 ) may accentuate this problem. There are several limitations to this study. The overall response rate (57%) was relatively low, which limited our ability to generalise to the whole Fellowship and limited our ability to construct predictive models. In addition, there is the potential presence of response bias (i.e. anaesthetists who chose not to respond may have had different practice (i.e. inaccuracies in recollection, particularly for a procedure that is performed infrequently). We did not request information about patient position and depth of sedation or general anaesthesia. Finally, we made many statistical comparisons on a relatively small sample, so the chances of both type I and type II errors should be considered.
In conclusion, wide variation exists in the practice of sedation and monitoring for endoscopy in adult patients by Australian anaesthetists, with respect to choice of agents and depth of sedation. A well-designed randomised controlled trial is needed outcome following endoscopy.
